You are here: Industry Insights > Parkinson

News List

Alterity Therapeutics Announces Publication of Data Demonstrating ATH434 is Neuroprotective and Improves Motor Function prnasia
July 16, 2021
Alterity Therapeutics, a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative conditions, announced that Movement Disorders, the official journal of the International Parkinson and Movement Disorder Society ...
Supernus Submits SPN-830 NDA for Apomorphine Infusion Pump americanpharmaceuticalreview
September 22, 2020
Supernus Pharmaceuticals has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its apomorphine infusion pump (SPN-830) for the continuous treatment of ON-OFF episodes in adults with Parkinson’s disease (PD) ...
Biogen and Denali sign Parkinson’s drug deal worth $2bn pharmaceutical-technology
August 10, 2020
Biogen has entered a binding agreement with Denali Therapeutics to jointly develop and commercialise therapeutics for Parkinson’s disease.
Zydus Cadila gets tentative US FDA approval for Carbidopa and Levodopa extended-release capsules expresspharma
August 03, 2020
This medication is used to treat the symptoms of Parkinson’s disease or Parkinson-like conditions.
World Brain Day 2020 "Moves to End Parkinson's Disease" prnasia
July 20, 2020
On July 22, the World Federation of Neurology (WFN) is partnering with the International Parkinson and Movement Disorder Society to support the 6th Annual World Brain Day. This year, World Brain Day is dedicated to raising awareness for Parkinson's Diseas
Parkinson's Therapy Funded by NJFF Receives FDA Approval, Advances to Market americanpharmaceuticalreview
June 01, 2020
The Michael J. Fox Foundation for Parkinson's Research (MJFF) announces a milestone in the Foundation's impact on the Parkinson's disease (PD) therapeutic landscape.
Multi-arm, multi-stage clinical trials the way forward for Parkinson’s research, says study europeanpharmaceuticalreview
May 11, 2020
According to a new review, multi-arm and multi-stage clinical trials should be used to evaluate potential Parkinson’s treatments.
Nanohybrid drug delivery vehicle could help treat Alzheimer’s europeanpharmaceuticalreview
April 29, 2020
The chitosan drug delivery vehicle could be used for administering polyphenol ellagic acid (EA), a potential antioxidant treatment for Alzheimer’s and Parkinson’s.
Annovis Issued Patent for Method of Treating Parkinson’s, Other Lewy Body Diseases americanpharmaceuticalreview
March 09, 2020
Annovis Bio was issued a patent (US 10,383,851) in August 2019 for a method of treating Parkinson’s disease, Lewy body dementia and other Lewy body diseases in humans by administering its lead compound ...
GB Sciences Announces Results from Parkinson's Disease Study americanpharmaceuticalreview
December 23, 2019
GB Sciences announced preclinical results for their Parkinson's disease (PD) formulations from the midterm report for their preclinical study being performed by Dr. Lee Ellis of ...

Previous page 1 2 3 4 5 6 7 8 9 Next page